HEMPLAB Institute & AlphaCAT Partnership
We are particularly happy to announce our cooperation agreement with AlphaCAT. They are the pioneers of affordable and individualised cannabinoid testing and profiling kits. Based on their advanced TLC methodology and unique quantification algorithm, AlphaCAT is able to provide a unique range of services for targeted audiences (For details on the AlphaCAT methodology click here). We are very excited at the prospect of offering their technology to our clients.
Cannabinoid Certification & Quality Control
In addition to technical exchange the cooperation extends onto shared client networking and regional distributions of analytical burden. This strengthens the position of both laboratories through service diversification and deeper market penetration. Mr Beguerie, AlphaCAT founder, has been trained by Bedrocan BV in the Netherlands and he is a recognised figure of the phyto-cannabinoids & medical cannabis community as part of the Board of Directors of IACM (International Association for Cannabinoids as Medicine). Furthermore, he is a Patient Representative and co-founding member of IMCPC (International Medical Cannabis Patient Coalition) – representing patient’s rights at the United Nations in the UNGASS. His experience and his network represent a solid foundation and opportunity for HempLab institute to be in the forefront of cannabinoid quality control on a European level.